Sage Rhino Capital LLC Novartis Ag Transaction History

Sage Rhino Capital LLC

  • $407 Million
  • Q2 2024

A detailed history of Sage Rhino Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Sage Rhino Capital LLC holds 7,847 shares of NVS stock, worth $894,165. This represents 0.21% of its overall portfolio holdings.

Number of Shares
7,847
Previous 7,806 0.53%
Holding current value
$894,165
Previous $755,000 10.6%
% of portfolio
0.21%
Previous 0.18%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
BUY
$92.57 - $107.37 $3,795 - $4,402
41 Added 0.53%
7,847 $835,000
Q1 2024

Apr 26, 2024
BUY
$95.27 - $108.47 $15,433 - $17,572
162 Added 2.12%
7,806 $755,000
Q4 2023

Feb 05, 2024
BUY
$92.27 - $101.54 $6,458 - $7,107
70 Added 0.92%
7,644 $771,000
Q3 2023

Oct 26, 2023
BUY
$94.73 - $105.13 $36,376 - $40,369
384 Added 5.34%
7,574 $771,000
Q2 2023

Jul 31, 2023
BUY
$92.52 - $104.91 $24,702 - $28,010
267 Added 3.86%
7,190 $725,000
Q1 2023

Apr 20, 2023
BUY
$80.03 - $92.81 $9,603 - $11,137
120 Added 1.76%
6,923 $636,000
Q4 2022

Jan 31, 2023
BUY
$75.55 - $92.52 $30,144 - $36,915
399 Added 6.23%
6,803 $617,000
Q3 2022

Oct 24, 2022
SELL
$74.61 - $87.26 $83,936 - $98,167
-1,125 Reduced 14.94%
6,404 $487,000
Q2 2022

Jul 28, 2022
BUY
$80.52 - $93.75 $61,597 - $71,718
765 Added 11.31%
7,529 $636,000
Q1 2022

Apr 27, 2022
BUY
$80.11 - $90.62 $60,082 - $67,965
750 Added 12.47%
6,764 $594,000
Q4 2021

Feb 04, 2022
BUY
$79.7 - $88.13 $13,708 - $15,158
172 Added 2.94%
6,014 $526,000
Q3 2021

Oct 18, 2021
BUY
$81.78 - $95.14 $3,925 - $4,566
48 Added 0.83%
5,842 $478,000
Q2 2021

Jul 27, 2021
BUY
$85.24 - $94.15 $48,075 - $53,100
564 Added 10.78%
5,794 $529,000
Q1 2021

May 04, 2021
BUY
$83.5 - $98.47 $14,278 - $16,838
171 Added 3.38%
5,230 $447,000
Q4 2020

Feb 03, 2021
BUY
$78.07 - $94.43 $312 - $377
4 Added 0.08%
5,059 $478,000
Q3 2020

Nov 05, 2020
SELL
$82.14 - $91.0 $8,953 - $9,919
-109 Reduced 2.11%
5,055 $440,000
Q2 2020

Jul 30, 2020
BUY
$80.93 - $91.1 $33,585 - $37,806
415 Added 8.74%
5,164 $451,000
Q1 2020

Apr 29, 2020
BUY
$70.67 - $99.01 $1,837 - $2,574
26 Added 0.55%
4,749 $392,000
Q4 2019

Jan 31, 2020
BUY
$84.35 - $95.37 $3,542 - $4,005
42 Added 0.9%
4,723 $443,000
Q3 2019

Oct 25, 2019
SELL
$85.54 - $94.26 $6,672 - $7,352
-78 Reduced 1.64%
4,681 $407,000
Q2 2019

Aug 20, 2019
BUY
$75.4 - $92.8 $13,798 - $16,982
183 Added 4.0%
4,759 $435,000
Q1 2019

Apr 18, 2019
BUY
$75.32 - $86.15 $344,664 - $394,222
4,576 New
4,576 $440,000

Others Institutions Holding NVS

# of Institutions
1,425
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email